Axsome Therapeutics to Report First Quarter 2026 Financial Results on May 4
Axsome Therapeutics, a biopharmaceutical company specialized in CNS disorder treatments, announced it will report its Q1 2026 financial results before the U.S. markets open on May 4, 2026, followed by a conference call to discuss the results and provide a business update.